1.TGF-β2 enhances invasion ability of glioma stem cell through matrix metalloproteinase pathway
ZHANG Dongyong ; WANG Yiwei2 ; ZHANG Luyang1 ; WANG Wei1 ; LIU Qiang1 ; LI Zhenhang1 ; WANG Yunjie1 ; QIU Bo1
Chinese Journal of Cancer Biotherapy 2018;25(4):357-362
[Abstract] Objective: To study the effect and possible mechanism of TGF-β2 on the invasion of glioma stem cells (GSCs). Methods: Tumor tissues of 8 patients with glioblastoma multiforme, who underwent resection at Department of Neurosurgery of the FirstAffiliated Hospital of China Medical University duringApril 2016 toApril 2017, were collected. The primary culture of glioma cells were conducted with trypsin digestion. Partial primary glioma cells were seeded into serum-free DMEM/F12 culture medium containing EGF, bFGF and B27 to obtain suspension of tumor spheres. Immunoflurenscent staining and differentiation assay were used to detect whether the tumor spheres were GSCs. TGF-β2 secretion ability of GSCs was determined by ELISAassay.After transfection of TGF-β2 siRNA, the invasion ability of glioma stem cells was determined by Transwell assay. Western blotting was used to examine the effect of TGF-β2 on expression of matrix metalloproteinases (MMP) in glioma stem cells. Results: The suspended tumor spheres were proved to be GSCs by immunofluorescent staining and differentiation assay; the tumor spheres expressed the marker of GSCs(CD133)and had the ability to multi-differentiate (glia and neuronal cells). Compared with the primary glioma cells, Glioma stem cells exerted significantly improved TGF-β2 secretion ability ([74.13±3.63] vs [46.13±2.61] pg/ml, P<0.05); and TGF-β2 silencing significantly reduced the invasion ability of glioma stem cells ([105.71±8.69] vs [63.67±5.93], P<0.05) and inhibited MMP-2 and MMP-9 expressions. Conclusion: TGF-β2 can promote the invasiveness of glioma stem cells through MMP-2 and MMP-9 pathway.
2.SPIDR significantly suppressed in tissues of small cell lung cancer promotes NCI-H446 cells proliferation by reducing serum dependence
ZHANG Zezhong ; JIA Yulin ; QILGER Bao1 ; FANG Yi1 ; LI Chunhui1 ; LI Jianlei1 ; GU Ye2a ; DENG Zixin1 ; ZHANG Haiping2b ; MA Wei1
Chinese Journal of Cancer Biotherapy 2018;25(10):1026-1033
Objective: The present study was aimed to explore the role and distinctive mechanism of SPIDR, the key regulatory protein of homologous recombination pathway, in progression of small cell lung cancer (SCLC). Methods: 60 SCLC specimens and 44 normal lung tissues were collected from the patients undergoing tumor resection and bronchoscopic puncture in Shanghai Pulmonary Hospital Affiliated to Tongji University from January 2013 to January 2015. The expression of SPIDR in clinical samples and NCIH446 (SCLC cell line) and MRC-5 (normal cell line) were assayed by Real-time PCR. The role of SPIDR in SCLC was investigated in vivo and in vitro by the expression of SPIDR were artificially modified in NCI-H446. Results: Smoking was significantly associated with the occurrence of SCLC (P<0.01). The expression of SPIDR mRNAin SCLC tissues was lower than that of normal lung tissues (P <0.01), and the SPIDR transcriptional and translational levels of NCI-H446 cells were also lower than that of MRC-5.Although there is no significant changes of cell growth rate and susceptibility to cisplatin and etoposide in the NCI-H446 cells overexpressing SPIDR. However, the volume of xenograft tumors of overexpressed SPIDR group decreased by 58.99% (P<0.01) and 61.84% (P<0.01) than that of the original NCI-H446 cells and the NCI-H446 cells transfected with vector (pMSCV) and the average tumor mass decreased by 61.70% (P<0.01) and 70.25% (P<0.01) respectively. When the fetal bovine serum content in the medium was reduced to 3%, the growth rate of NCI-H446 cells overexpressing SPIDR was 22.33% (P<0.01) and 20.24% (P<0.05) lower than that of the original NCIH446 cells and control group, the similar results were obtained from the 1% serum concentration experiment as well. Conclusion: The expression of SPIDR, the key regulatory protein in the DNAdouble strand break homologous recombination repair pathway, was significantly suppressed in SCLC tissues, which markedly accelerated the growth of NCI-H446 cells in vivo and reduced the reliance of NCIH446 cells to the serum. The detailed mechanism is worthy of further investigation.
3.The role of hypoxia-induced circ_0007766 expression in the proliferation, migration and invasion of PCa cells
ZHAO Ziqi1 ; ZHANG Min1 ; YANG Tao1 ; YANG Li2 ; LIAO Guoling1 ; ZHANG Wei1 ; CHU Yuankui1,3
Chinese Journal of Cancer Biotherapy 2025;32(5):460-468
[摘 要] 目的:探讨环化自erb-b2受体酪氨酸激酶2(ERBB2)基因的circ_0007766分子在前列腺癌(PCa)细胞中的作用及缺氧对其表达调控的影响。方法:qRT-PCR检测circ_0007766分子在PCa细胞及组织中的表达;分别转染circ0007766的siRNA至PCa细胞DU145和PC3中,平板克隆实验、CCK-8实验和Transwell 实验检测circ_0007766敲低对PCa细胞克隆形成、增殖、迁移和侵袭能力的影响;厌氧袋法建立DU145和PC3细胞的缺氧细胞模型,WB法检测缺氧通路关键分子HIF-1α的蛋白表达,qRT-PCR检测缺氧模型细胞中circ_0007766分子的表达,WB检测RNA结合蛋白真核翻译起始因子4A3(EIF4A3)的蛋白水平表达,RNA免疫沉淀(RIP)法检测缺氧条件下EIF4A3与circ_0007766的结合,qRT-PCR进一步检测缺氧条件下敲低EIF4A3对circ_0007766表达的影响。结果:circ_0007766在PCa细胞(P < 0.01)及PCa组织(P < 0.05)中呈高表达;敲低circ_0007766(P < 0.05或P < 0.01)能显著抑制PCa细胞的增殖、迁移和侵袭能力(均P < 0.01)。缺氧条件下HIF-1α蛋白表达增加,表明缺氧细胞模型建立成功。qRT-PCR检测结果显示,相较于常氧组,缺氧组circ_0007766的表达显著升高(P < 0.01),WB法检测结果显示缺氧组细胞中EIF4A3 的蛋白表达增强。RIP实验结果显示,circ_0007766在EIF4A3富集组高度富集(P < 0.01)。qRT-PCR检测结果显示,缺氧可显著促进circ_0007766的表达,同时,敲低EIF4A3分子可显著降低缺氧诱导的circ_0007766的表达(P < 0.05或P < 0.01)。结论: circ_0007766在PCa细胞中扮演着促癌分子的角色,其表达形成与缺氧条件下EIF4A3分子的调控有关。
4.Major progress made in γδT cell-based tumor immunotherapy in 2023
ZHAO Yueqi1 ; ZHANG Jianmin1,2 ; CHEN Hui1,2 ; HE Wei1
Chinese Journal of Cancer Biotherapy 2024;31(3):211-218
[摘 要] γδT细胞是一类表达γδTCR异源二聚体的特殊固有免疫T细胞。过去,缺乏对其全面系统的基础研究,在其发育、分化、增殖、活化、效应和耗竭等所有环节仍有很多问题尚不清楚。然而,因为成熟的γδT细胞优势定植于皮肤、消化道、呼吸道、生殖道等肿瘤高发的黏膜组织,能以MHC非限制性的方式直接识别和杀伤多种肿瘤细胞,在肿瘤免疫治疗领域具有不可替代的优势,近年来其应用异军突起,发展迅速,也因此反过来促进了基础研究的深入,取得了一些亮眼的进展。本文对2023年γδT细胞在肿瘤免疫治疗领域的重大进展进行述评,主要集中在γδT细胞肿瘤抗原识别机制、肿瘤微环境中γδT细胞的功能调控、γδT细胞抗肿瘤细胞毒活性的机制、新型基于γδT细胞的肿瘤免疫治疗协同增效策略四个方面,以期推动γδT细胞在肿瘤免疫治疗领域的进一步发展,为临床γδT细胞应用协同增效的策略提供新的思路。